Michael Fricker

19PUBLICATIONS
76CO-AUTHORS
Respiratory diseasesNaturopathyEpidemiological modellingAllergyMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Oct 22, 2025
COPD: the role of neutrophils in inflammation, pathophysiology, and as drug targets.

Michael Fricker, Ravi Lokwani

|May 23, 2025
Unlocking Asthma Remission: Key Insights From an Expert Roundtable Discussion.

Dennis Thomas, Hayley Lewthwaite, Peter G Gibson

|Oct 14, 2024
Distinct trajectories of treatment response to mepolizumab toward remission in patients with severe eosinophilic asthma.

Yuto Hamada, Dennis Thomas, Erin S Harvey

|Aug 08, 2024
Mepolizumab depletes inflammatory but preserves homeostatic eosinophils in severe asthma.

Michael Fricker, John Harrington, Sarah A Hiles

|Feb 08, 2024
Faecal microbial transfer and complex carbohydrates mediate protection against COPD.

Kurtis F Budden, Shakti D Shukla, Kate L Bowerman

|Jul 01, 2022
Adverse roles of mast cell chymase-1 in COPD.

Gang Liu, Andrew G Jarnicki, Keshav R Paudel

Pageof 4